IRINOTECAN, REGORAFENIB, Stivarga 40 mg film-coated tablets
PROICM 2018-01 NEX
Phase 3 small_molecule active
Quick answer
IRINOTECAN, REGORAFENIB, Stivarga 40 mg film-coated tablets for Metastatic colorectal cancer is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Metastatic colorectal cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active